Annual summary of publications

Publications (original articles or review articles) published in 2011 from OUS - Department of Cardiology B (Div Med)

90 publications found

Afzal F, Qvigstad E, Aronsen JM, Moltzau LR, Sjaastad I, Skomedal T, Osnes JB, Levy FO (2011)
Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle
Naunyn Schmiedebergs Arch Pharmacol, 384 (6), 543-53
DOI 10.1007/s00210-011-0670-6, PubMed 21901315

Agewall S (2011)
[New European guidelines for myocardial infarction without ST-segment elevation. Quicker diagnosis saves money--demands for angiography also during weekends costs more]
Lakartidningen, 108 (50), 2644-5
PubMed 22474779

Agewall S (2011)
Some aspects of preventing coronary heart disease
Angiology, 63 (1), 17-23
DOI 10.1177/0003319711407060, PubMed 21555307

Agewall S, Atar D (2011)
[New European guidelines for acute myocardial infarction]
Tidsskr Nor Laegeforen, 131 (23), 2340
DOI 10.4045/tidsskr.11.1133, PubMed 22139110

Agewall S, Daniel M, Eurenius L, Ekenbäck C, Skeppholm M, Malmqvist K, Hofman-Bang C, Collste O, Frick M, Henareh L, Jernberg T, Tornvall P (2011)
Risk factors for myocardial infarction with normal coronary arteries and myocarditis compared with myocardial infarction with coronary artery stenosis
Angiology, 63 (7), 500-3
DOI 10.1177/0003319711429560, PubMed 22210737

Agewall S, Eurenius L, Hofman-Bang C, Malmqvist K, Frick M, Jernberg T, Tornvall P (2011)
Myocardial infarction with angiographically normal coronary arteries
Atherosclerosis, 219 (1), 10-4
DOI 10.1016/j.atherosclerosis.2011.04.036, PubMed 21601856

Agewall S, Tjora S (2011)
Physical exertion may cause high troponin levels
Tidsskr Nor Laegeforen, 131 (22), 2226
DOI 10.4045/tidsskr.11.0815, PubMed 22085943

Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P et al. (2011)
Apixaban with antiplatelet therapy after acute coronary syndrome
N Engl J Med, 365 (8), 699-708
DOI 10.1056/NEJMoa1105819, PubMed 21780946

Andersen GØ, Knudsen EC, Aukrust P, Yndestad A, Oie E, Müller C, Seljeflot I, Ueland T (2011)
Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
Heart, 97 (6), 460-5
DOI 10.1136/hrt.2010.206714, PubMed 21270073

Andersen GØ, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
Diabetes, 60 (5), 1544-51
DOI 10.2337/db10-1493, PubMed 21464440

Aradi D, Kuliczkowski W, Atar D, Serebruany VL (2011)
Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrel
Thromb Haemost, 107 (2), 338-45
DOI 10.1160/TH11-09-0622, PubMed 22186910

ARB Trialists Collaboration (2011)
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals
J Hypertens, 29 (4), 623-35
DOI 10.1097/HJH.0b013e328344a7de, PubMed 21358417

Ariansen I, Dammen T, Abdelnoor M, Tveit A, Gjesdal K (2011)
Mental health and sleep in permanent atrial fibrillation patients from the general population
Clin Cardiol, 34 (5), 327-31
DOI 10.1002/clc.20883, PubMed 21319172

Ariansen I, Edvardsen E, Borchsenius F, Abdelnoor M, Tveit A, Gjesdal K (2011)
Lung function and dyspnea in patients with permanent atrial fibrillation
Eur J Intern Med, 22 (5), 466-70
DOI 10.1016/j.ejim.2011.06.010, PubMed 21925054

Ariansen I, Reims HM, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, Okin PM, Kjeldsen SE, Dahlöf B, Wachtell K (2011)
Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: the LIFE study
Blood Press, 21 (1), 6-11
DOI 10.3109/08037051.2011.622978, PubMed 22070095

Banach M, Michalska M, Kjeldsen SE, Małyszko J, Mikhailidis DP, Rysz J (2011)
What should be the optimal levels of blood pressure: Does the J-curve phenomenon really exist?
Expert Opin Pharmacother, 12 (12), 1835-44
DOI 10.1517/14656566.2011.579106, PubMed 21517698

Berdal JE, Mollnes TE, Wæhre T, Olstad OK, Halvorsen B, Ueland T, Laake JH, Furuseth MT, Maagaard A, Kjekshus H, Aukrust P, Jonassen CM (2011)
Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
J Infect, 63 (4), 308-16
DOI 10.1016/j.jinf.2011.07.004, PubMed 21781987

Bjørnstad JL, Skrbic B, Marstein HS, Hasic A, Sjaastad I, Louch WE, Florholmen G, Christensen G, Tønnessen T (2011)
Inhibition of SMAD2 phosphorylation preserves cardiac function during pressure overload
Cardiovasc Res, 93 (1), 100-10
DOI 10.1093/cvr/cvr294, PubMed 22049534

Bjørnstad JL, Skrbic B, Sjaastad I, Bjørnstad S, Christensen G, Tønnessen T (2011)
A mouse model of reverse cardiac remodelling following banding-debanding of the ascending aorta
Acta Physiol (Oxf), 205 (1), 92-102
DOI 10.1111/j.1748-1716.2011.02369.x, PubMed 21974781

Bodegard J, Skretteberg PT, Gjesdal K, Pyörälä K, Kjeldsen SE, Liestøl K, Erikssen G, Erikssen J (2011)
Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men
J Intern Med, 271 (6), 581-8
DOI 10.1111/j.1365-2796.2011.02480.x, PubMed 22061296

Bøhmer E, Kristiansen IS, Arnesen H, Halvorsen S (2011)
Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction
Eur J Cardiovasc Prev Rehabil, 18 (5), 717-23
DOI 10.1177/1741826711398425, PubMed 21450598

Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
BMC Infect Dis, 11, 75
DOI 10.1186/1471-2334-11-75, PubMed 21435254

Byrkjeland R, Nilsson BB, Westheim AS, Arnesen H, Seljeflot I (2011)
Inflammatory markers as related to disease severity in patients with chronic heart failure: limited effects of exercise training
Scand J Clin Lab Invest, 71 (7), 598-605
DOI 10.3109/00365513.2011.598943, PubMed 21831004

Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) (2011)
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Atherosclerosis, 217 (1), 3-46
DOI 10.1016/j.atherosclerosis.2011.06.028, PubMed 21882396

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H et al. (2011)
Dronedarone in high-risk permanent atrial fibrillation
N Engl J Med, 365 (24), 2268-76
DOI 10.1056/NEJMoa1109867, PubMed 22082198

European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees (2011)
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Eur Heart J, 32 (14), 1769-818
DOI 10.1093/eurheartj/ehr158, PubMed 21712404

Finsen AV, Lunde IG, Sjaastad I, Østli EK, Lyngra M, Jarstadmarken HO, Hasic A, Nygård S, Wilcox-Adelman SA, Goetinck PF, Lyberg T, Skrbic B, Florholmen G, Tønnessen T, Louch WE, Djurovic S, Carlson CR, Christensen G (2011)
Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway
PLoS One, 6 (12), e28302
DOI 10.1371/journal.pone.0028302, PubMed 22164265

Ghanavatian S, Stein RA, Atar D, Hole L, Agewall S (2011)
The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction
Clin Lab, 57 (9-10), 771-6
PubMed 22029194

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P et al. (2011)
Apixaban versus warfarin in patients with atrial fibrillation
N Engl J Med, 365 (11), 981-92
DOI 10.1056/NEJMoa1107039, PubMed 21870978

Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K (2011)
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Circulation, 125 (2), 346-53
DOI 10.1161/CIRCULATIONAHA.111.049759, PubMed 22147903

Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Hammer-Hansen S, Køber L, Willenheimer R, Wachtell K (2011)
Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data)
Am J Cardiol, 108 (4), 541-7
DOI 10.1016/j.amjcard.2011.03.084, PubMed 21624542

Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Nienaber CA, Ray S, Egstrup K, Pedersen TR, Køber L, Willenheimer R, Wachtell K (2011)
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Int J Cardiol, 166 (1), 72-6
DOI 10.1016/j.ijcard.2011.09.064, PubMed 21996417

Grimsmo J, Maehlum S, Moelstad P, Arnesen H (2011)
Mortality and cardiovascular morbidity among long-term endurance male cross country skiers followed for 28-30 years
Scand J Med Sci Sports, 21 (6), e351-8
DOI 10.1111/j.1600-0838.2011.01307.x, PubMed 21477204

Grøgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A (2011)
Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris
Scand J Clin Lab Invest, 71 (4), 322-9
DOI 10.3109/00365513.2011.565367, PubMed 21463159

Hallén J, Jensen JK, Buser P, Jaffe AS, Atar D (2011)
Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction
Acute Card Care, 13 (1), 48-51
DOI 10.3109/17482941.2010.538698, PubMed 21244230

Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, ESC Committee for Practice Guidelines (2011)
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
Eur Heart J, 32 (23), 2999-3054
DOI 10.1093/eurheartj/ehr236, PubMed 21873419

Hassellund SS, Flaa A, Sandvik L, Kjeldsen SE, Rostrup M (2011)
Effects of anthocyanins on blood pressure and stress reactivity: a double-blind randomized placebo-controlled crossover study
J Hum Hypertens, 26 (6), 396-404
DOI 10.1038/jhh.2011.41, PubMed 21544087

Hodt A, Hisdal J, Stugaard M, Stranden E, Atar D, Steine K (2011)
Reduced preload elicits increased LV twist in healthy humans: an echocardiographic speckle-tracking study during lower body negative pressure
Clin Physiol Funct Imaging, 31 (5), 382-9
DOI 10.1111/j.1475-097X.2011.01029.x, PubMed 21771258

Holm S, Ueland T, Dahl TB, Michelsen AE, Skjelland M, Russell D, Nymo SH, Krohg-Sørensen K, Clausen OP, Atar D, Januzzi JL, Aukrust P, Jensen JK, Halvorsen B (2011)
Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke
PLoS One, 6 (12), e28785
DOI 10.1371/journal.pone.0028785, PubMed 22174896

Holme I, Pedersen TR, Boman K, Egstrup K, Gerdts E, Kesäniemi YA, Malbecq W, Ray S, Rossebø AB, Wachtell K, Willenheimer R, Gohlke-Bärwolf C (2011)
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis
Heart, 98 (5), 377-83
DOI 10.1136/heartjnl-2011-300475, PubMed 22155702

Hopp E, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ (2011)
Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study
J Cardiovasc Magn Reson, 13, 22
DOI 10.1186/1532-429X-13-22, PubMed 21414223

Hussain RI, Afzal F, Mørk HK, Aronsen JM, Sjaastad I, Osnes JB, Skomedal T, Levy FO, Krobert KA (2011)
Cyclic AMP-dependent inotropic effects are differentially regulated by muscarinic G(i)-dependent constitutive inhibition of adenylyl cyclase in failing rat ventricle
Br J Pharmacol, 162 (4), 908-16
DOI 10.1111/j.1476-5381.2010.01097.x, PubMed 21039419

Jensen JK, Hallén J, Lund T, Madsen LH, Grieg Z, Januzzi JL, Atar D (2011)
Troponin I degradation in serum of patients with acute ischemic stroke
Scand J Clin Lab Invest, 71 (1), 74-80
DOI 10.3109/00365513.2010.542485, PubMed 21214502

Julius S, Palatini P, Kjeldsen SE, Zanchetti A, Weber MA, McInnes GT, Brunner HR, Mancia G, Schork MA, Hua TA, Holzhauer B, Zappe D, Majahalme S, Jamerson K, Koylan N (2011)
Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension
Am J Cardiol, 109 (5), 685-92
DOI 10.1016/j.amjcard.2011.10.025, PubMed 22169130

Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, Erlund I, Serafini M, Bastani N, Remberg SF, Borge GI, Carlsen MH, Bøhn SK, Myhrstad MC, Dragsted LO, Duttaroy AK, Haffner K, Laake P, Drevon CA, Arnesen H, Collins A, Tonstad S, Blomhoff R (2011)
Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers
Br J Nutr, 106 (4), 557-71
DOI 10.1017/S0007114511000353, PubMed 21806852

Kirkhus B, Lamglait A, Eilertsen KE, Falch E, Haider T, Vik H, Hoem N, Hagve TA, Basu S, Olsen E, Seljeflot I, Nyberg L, Elind E, Ulven SM (2011)
Effects of similar intakes of marine n-3 fatty acids from enriched food products and fish oil on cardiovascular risk markers in healthy human subjects
Br J Nutr, 107 (9), 1339-49
DOI 10.1017/S0007114511004508, PubMed 21917191

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GO (2011)
Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
BMC Endocr Disord, 11, 14
DOI 10.1186/1472-6823-11-14, PubMed 21801387

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2011)
Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction
J Thromb Haemost, 9 (8), 1468-74
DOI 10.1111/j.1538-7836.2011.04377.x, PubMed 21624046

Kubon C, Mistry NB, Grundvold I, Halvorsen S, Kjeldsen SE, Westheim AS (2011)
The role of beta-blockers in the treatment of chronic heart failure
Trends Pharmacol Sci, 32 (4), 206-12
DOI 10.1016/j.tips.2011.01.006, PubMed 21376403

Larsen KO, Yndestad A, Sjaastad I, Løberg EM, Goverud IL, Halvorsen B, Jia J, Andreassen AK, Husberg C, Jonasson S, Lipp M, Christensen G, Aukrust P, Skjønsberg OH (2011)
Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation
Am J Physiol Lung Cell Mol Physiol, 301 (1), L50-9
DOI 10.1152/ajplung.00048.2010, PubMed 21498626

Lunde IG, Aronsen JM, Kvaløy H, Qvigstad E, Sjaastad I, Tønnessen T, Christensen G, Grønning-Wang LM, Carlson CR (2011)
Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure
Physiol Genomics, 44 (2), 162-72
DOI 10.1152/physiolgenomics.00016.2011, PubMed 22128088

Melki D, Lind S, Agewall S, Jernberg T (2011)
Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations
Scand Cardiovasc J, 45 (4), 198-204
DOI 10.3109/14017431.2011.565792, PubMed 21428843

Mistry N, Abdelnoor M, Seljeflot I, Hoffmann P, Bøhmer E, Bjørnerheim R, Kjeldsen SE, Halvorsen S (2011)
Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels 3 months after myocardial infarction are more strongly associated with magnetic resonance-determined ejection fraction than NTproBNP levels in the acute phase
J Card Fail, 17 (6), 479-86
DOI 10.1016/j.cardfail.2011.02.006, PubMed 21624736

Mistry N, Beitnes JO, Halvorsen S, Abdelnoor M, Hoffmann P, Kjeldsen SE, Smith G, Aakhus S, Bjørnerheim R (2011)
Assessment of left ventricular function in ST-elevation myocardial infarction by global longitudinal strain: a comparison with ejection fraction, infarct size, and wall motion score index measured by non-invasive imaging modalities
Eur J Echocardiogr, 12 (9), 678-83
DOI 10.1093/ejechocard/jer113, PubMed 21810829

Munkvik M, Lunde PK, Aronsen JM, Birkeland JA, Sjaastad I, Sejersted OM (2011)
Attenuated fatigue in slow twitch skeletal muscle during isotonic exercise in rats with chronic heart failure
PLoS One, 6 (7), e22695
DOI 10.1371/journal.pone.0022695, PubMed 21799933

Nilsson L, Hallén J, Atar D, Jonasson L, Swahn E (2011)
Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction
Heart, 98 (1), 31-6
DOI 10.1136/heartjnl-2011-300079, PubMed 21727201

O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U et al. (2011)
Effect of nesiritide in patients with acute decompensated heart failure
N Engl J Med, 365 (1), 32-43
DOI 10.1056/NEJMoa1100171, PubMed 21732835

Okin PM, Kjeldsen SE, Dahlöf B, Devereux RB (2011)
Racial differences in incident heart failure during antihypertensive therapy
Circ Cardiovasc Qual Outcomes, 4 (2), 157-64
DOI 10.1161/CIRCOUTCOMES.110.960112, PubMed 21304095

Okin PM, Kjeldsen SE, Julius S, Dahlöf B, Devereux RB (2011)
Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study
Heart Rhythm, 9 (4), 531-7
DOI 10.1016/j.hrthm.2011.11.008, PubMed 22079554

Okin PM, Kjeldsen SE, Julius S, Hille DA, Dahlöf B, Devereux RB (2011)
Effect of changing heart rate during treatment of hypertension on incidence of heart failure
Am J Cardiol, 109 (5), 699-704
DOI 10.1016/j.amjcard.2011.10.026, PubMed 22154318

Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators (2011)
Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study
Eur J Heart Fail, 13 (4), 384-91
DOI 10.1093/eurjhf/hfq224, PubMed 21239405

Olsen MH, Wachtell K, Ibsen H, Lindholm L, Kjeldsen SE, Omvik P, Nieminen MS, Dahlöf B, Okin PM, Devereux RB (2011)
Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy
J Hypertens, 29 (5), 997-1004
DOI 10.1097/HJH.0b013e328344daa3, PubMed 21358415

Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2011)
Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study
Cardiovasc Diabetol, 10, 110
DOI 10.1186/1475-2840-10-110, PubMed 22141572

Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I (2011)
Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease
Clin Chim Acta, 413 (1-2), 113-20
DOI 10.1016/j.cca.2011.09.004, PubMed 21963461

Patrono C, Andreotti F, Arnesen H, Badimon L, Baigent C, Collet JP, De Caterina R, Gulba D, Huber K, Husted S, Kristensen SD, Morais J, Neumann FJ, Rasmussen LH, Siegbahn A, Steg PG, Storey RF, Van de Werf F, Verheugt F (2011)
Antiplatelet agents for the treatment and prevention of atherothrombosis
Eur Heart J, 32 (23), 2922-32
DOI 10.1093/eurheartj/ehr373, PubMed 22019823

Pettersen AA, Arnesen H, Opstad TB, Seljeflot I (2011)
The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel
Thromb J, 9, 4
DOI 10.1186/1477-9560-9-4, PubMed 21426546

Provan SA, Angel K, Semb AG, Mowinckel P, Agewall S, Atar D, Kvien TK (2011)
Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year followup study of 108 patients with rheumatoid arthritis
J Rheumatol, 38 (4), 606-12
DOI 10.3899/jrheum.100689, PubMed 21239744

Provan SA, Semb AG, Hisdal J, Stranden E, Agewall S, Dagfinrud H, Angel K, Atar D, Kvien TK (2011)
Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study
Ann Rheum Dis, 70 (5), 812-7
DOI 10.1136/ard.2010.141523, PubMed 21288959

Reiner Ž, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegría E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs RH, Kjekshus JK, Perrone Filardi P, Riccardi G, Storey RF, David W, Clinical Practice Guidelines Committee of the Spanish Society of Cardiology (2011)
[ESC/EAS Guidelines for the management of dyslipidaemias]
Rev Esp Cardiol, 64 (12), 1168.e1-1168.e60
DOI 10.1016/j.recesp.2011.09.014, PubMed 22115524

Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A et al. (2011)
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
Trials, 12, 252
DOI 10.1186/1745-6215-12-252, PubMed 22129158

Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2011)
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
Lancet, 377 (9767), 741-50
DOI 10.1016/S0140-6736(11)60104-9, PubMed 21316752

Schwartz T, Sanner H, Husebye T, Flatø B, Sjaastad I (2011)
Cardiac dysfunction in juvenile dermatomyositis: a case-control study
Ann Rheum Dis, 70 (5), 766-71
DOI 10.1136/ard.2010.137968, PubMed 21216816

Serebruany VL, Miller M, Pokov AN, Lynch D, Jensen JK, Hallén J, Atar D (2011)
Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia
Cardiology, 118 (3), 187-94
DOI 10.1159/000329300, PubMed 21701167

Skretteberg PT, Grundvold I, Kjeldsen SE, Erikssen JE, Sandvik L, Liestøl K, Erikssen G, Pedersen TR, Bodegard J (2011)
HDL-cholesterol and prediction of coronary heart disease: modified by physical fitness? A 28-year follow-up of apparently healthy men
Atherosclerosis, 220 (1), 250-6
DOI 10.1016/j.atherosclerosis.2011.10.009, PubMed 22062589

Smedbakken L, Jensen JK, Hallén J, Atar D, Januzzi JL, Halvorsen B, Aukrust P, Ueland T (2011)
Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke
Stroke, 42 (9), 2453-8
DOI 10.1161/STROKEAHA.110.612440, PubMed 21757661

Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2011)
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction
Thromb Res, 130 (5), 765-8
DOI 10.1016/j.thromres.2011.11.045, PubMed 22192151

Søraas CL, Larstorp AC, Mangschau A, Tønnessen T, Kjeldsen SE, Bjørnerheim R (2011)
Echocardiographic demonstration of improved myocardial function early after coronary artery bypass graft surgery
Interact Cardiovasc Thorac Surg, 12 (6), 946-51
DOI 10.1510/icvts.2010.260414, PubMed 21422155

Steg PG, Huber K, Andreotti F, Arnesen H, Atar D, Badimon L, Bassand JP, De Caterina R, Eikelboom JA, Gulba D, Hamon M, Helft G, Fox KA, Kristensen SD, Rao SV, Verheugt FW, Widimsky P, Zeymer U, Collet JP (2011)
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology
Eur Heart J, 32 (15), 1854-64
DOI 10.1093/eurheartj/ehr204, PubMed 21715717

Stensaeth KH, Hoffmann P, Fossum E, Mangschau A, Sandvik L, Klow NE (2011)
Cardiac magnetic resonance visualizes acute and chronic myocardial injuries in myocarditis
Int J Cardiovasc Imaging, 28 (2), 327-35
DOI 10.1007/s10554-011-9812-7, PubMed 21347598

Svensson-Färbom P, Wahlstrand B, Almgren P, Dahlberg J, Fava C, Kjeldsen S, Hedner T, Melander O (2011)
A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients
J Hypertens, 29 (2), 388-95
DOI 10.1097/HJH.0b013e3283410390, PubMed 21052022

Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Perrone Filardi P, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines 2008-2010 and 2010-2012 Committees (2011)
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Atherosclerosis, 217 Suppl 1, S1-44
DOI 10.1016/j.atherosclerosis.2011.06.012, PubMed 21723445

Tømte O, Andersen GØ, Jacobsen D, Drægni T, Auestad B, Sunde K (2011)
Strong and weak aspects of an established post-resuscitation treatment protocol-A five-year observational study
Resuscitation, 82 (9), 1186-93
DOI 10.1016/j.resuscitation.2011.05.003, PubMed 21636202

Tømte Ø, Drægni T, Mangschau A, Jacobsen D, Auestad B, Sunde K (2011)
A comparison of intravascular and surface cooling techniques in comatose cardiac arrest survivors
Crit Care Med, 39 (3), 443-9
DOI 10.1097/CCM.0b013e318206b80f, PubMed 21169821

Ueland T, Aukrust P, Dahl CP, Husebye T, Solberg OG, Tønnessen T, Aakhus S, Gullestad L (2011)
Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis
J Intern Med, 270 (5), 452-60
DOI 10.1111/j.1365-2796.2011.02393.x, PubMed 21623962

Ueland T, Smedbakken LM, Hallén J, Atar D, Januzzi JL, Halvorsen B, Jensen JK, Aukrust P (2011)
Soluble CXCL16 and long-term outcome in acute ischemic stroke
Atherosclerosis, 220 (1), 244-9
DOI 10.1016/j.atherosclerosis.2011.10.004, PubMed 22055341

Von Lueder TG, Melsom MN, Atar D, Agewall S (2011)
Amyotrophic lateral sclerosis (ALS), a novel rare cause of elevated plasma troponin T levels
Clin Lab, 57 (7-8), 615-8
PubMed 21888026

Waehre A, Halvorsen B, Yndestad A, Husberg C, Sjaastad I, Nygård S, Dahl CP, Ahmed MS, Finsen AV, Reims H, Louch WE, Hilfiker-Kleiner D, Vinge LE, Roald B, Attramadal H, Lipp M, Gullestad L, Aukrust P, Christensen G (2011)
Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload
PLoS One, 6 (4), e18668
DOI 10.1371/journal.pone.0018668, PubMed 21533157

Weir MR, Bakris GL, Weber MA, Dahlof B, Devereux RB, Kjeldsen SE, Pitt B, Wright JT, Kelly RY, Hua TA, Hester RA, Velazquez E, Jamerson KA (2011)
Renal outcomes in hypertensive Black patients at high cardiovascular risk
Kidney Int, 81 (6), 568-76
DOI 10.1038/ki.2011.417, PubMed 22189843

Weiss TW, Arnesen H, Trøseid M, Kaun C, Hjerkinn EM, Huber K, Wojta J, Seljeflot I (2011)
Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose
Wien Klin Wochenschr, 123 (21-22), 650-4
DOI 10.1007/s00508-011-0028-6, PubMed 21842238

Weiss TW, Seljeflot I, Hjerkinn EM, Arnesen H (2011)
Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease
Int J Clin Pract, 65 (9), 939-44
DOI 10.1111/j.1742-1241.2011.02717.x, PubMed 21849008

Publications Division of Medicine

Publications (original articles or review articles) published in 2011 from OUS - Department of Cardiology B (Div Med)

90 publications found

Afzal F, Qvigstad E, Aronsen JM, Moltzau LR, Sjaastad I, Skomedal T, Osnes JB, Levy FO (2011)
Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle
Naunyn Schmiedebergs Arch Pharmacol, 384 (6), 543-53
DOI 10.1007/s00210-011-0670-6, PubMed 21901315

Agewall S (2011)
[New European guidelines for myocardial infarction without ST-segment elevation. Quicker diagnosis saves money--demands for angiography also during weekends costs more]
Lakartidningen, 108 (50), 2644-5
PubMed 22474779

Agewall S (2011)
Some aspects of preventing coronary heart disease
Angiology, 63 (1), 17-23
DOI 10.1177/0003319711407060, PubMed 21555307

Agewall S, Atar D (2011)
[New European guidelines for acute myocardial infarction]
Tidsskr Nor Laegeforen, 131 (23), 2340
DOI 10.4045/tidsskr.11.1133, PubMed 22139110

Agewall S, Daniel M, Eurenius L, Ekenbäck C, Skeppholm M, Malmqvist K, Hofman-Bang C, Collste O, Frick M, Henareh L, Jernberg T, Tornvall P (2011)
Risk factors for myocardial infarction with normal coronary arteries and myocarditis compared with myocardial infarction with coronary artery stenosis
Angiology, 63 (7), 500-3
DOI 10.1177/0003319711429560, PubMed 22210737

Agewall S, Eurenius L, Hofman-Bang C, Malmqvist K, Frick M, Jernberg T, Tornvall P (2011)
Myocardial infarction with angiographically normal coronary arteries
Atherosclerosis, 219 (1), 10-4
DOI 10.1016/j.atherosclerosis.2011.04.036, PubMed 21601856

Agewall S, Tjora S (2011)
Physical exertion may cause high troponin levels
Tidsskr Nor Laegeforen, 131 (22), 2226
DOI 10.4045/tidsskr.11.0815, PubMed 22085943

Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P et al. (2011)
Apixaban with antiplatelet therapy after acute coronary syndrome
N Engl J Med, 365 (8), 699-708
DOI 10.1056/NEJMoa1105819, PubMed 21780946

Andersen GØ, Knudsen EC, Aukrust P, Yndestad A, Oie E, Müller C, Seljeflot I, Ueland T (2011)
Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
Heart, 97 (6), 460-5
DOI 10.1136/hrt.2010.206714, PubMed 21270073

Andersen GØ, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
Diabetes, 60 (5), 1544-51
DOI 10.2337/db10-1493, PubMed 21464440

Aradi D, Kuliczkowski W, Atar D, Serebruany VL (2011)
Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrel
Thromb Haemost, 107 (2), 338-45
DOI 10.1160/TH11-09-0622, PubMed 22186910

ARB Trialists Collaboration (2011)
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals
J Hypertens, 29 (4), 623-35
DOI 10.1097/HJH.0b013e328344a7de, PubMed 21358417

Ariansen I, Dammen T, Abdelnoor M, Tveit A, Gjesdal K (2011)
Mental health and sleep in permanent atrial fibrillation patients from the general population
Clin Cardiol, 34 (5), 327-31
DOI 10.1002/clc.20883, PubMed 21319172

Ariansen I, Edvardsen E, Borchsenius F, Abdelnoor M, Tveit A, Gjesdal K (2011)
Lung function and dyspnea in patients with permanent atrial fibrillation
Eur J Intern Med, 22 (5), 466-70
DOI 10.1016/j.ejim.2011.06.010, PubMed 21925054

Ariansen I, Reims HM, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, Okin PM, Kjeldsen SE, Dahlöf B, Wachtell K (2011)
Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: the LIFE study
Blood Press, 21 (1), 6-11
DOI 10.3109/08037051.2011.622978, PubMed 22070095

Banach M, Michalska M, Kjeldsen SE, Małyszko J, Mikhailidis DP, Rysz J (2011)
What should be the optimal levels of blood pressure: Does the J-curve phenomenon really exist?
Expert Opin Pharmacother, 12 (12), 1835-44
DOI 10.1517/14656566.2011.579106, PubMed 21517698

Berdal JE, Mollnes TE, Wæhre T, Olstad OK, Halvorsen B, Ueland T, Laake JH, Furuseth MT, Maagaard A, Kjekshus H, Aukrust P, Jonassen CM (2011)
Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
J Infect, 63 (4), 308-16
DOI 10.1016/j.jinf.2011.07.004, PubMed 21781987

Bjørnstad JL, Skrbic B, Marstein HS, Hasic A, Sjaastad I, Louch WE, Florholmen G, Christensen G, Tønnessen T (2011)
Inhibition of SMAD2 phosphorylation preserves cardiac function during pressure overload
Cardiovasc Res, 93 (1), 100-10
DOI 10.1093/cvr/cvr294, PubMed 22049534

Bjørnstad JL, Skrbic B, Sjaastad I, Bjørnstad S, Christensen G, Tønnessen T (2011)
A mouse model of reverse cardiac remodelling following banding-debanding of the ascending aorta
Acta Physiol (Oxf), 205 (1), 92-102
DOI 10.1111/j.1748-1716.2011.02369.x, PubMed 21974781

Bodegard J, Skretteberg PT, Gjesdal K, Pyörälä K, Kjeldsen SE, Liestøl K, Erikssen G, Erikssen J (2011)
Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men
J Intern Med, 271 (6), 581-8
DOI 10.1111/j.1365-2796.2011.02480.x, PubMed 22061296

Bøhmer E, Kristiansen IS, Arnesen H, Halvorsen S (2011)
Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction
Eur J Cardiovasc Prev Rehabil, 18 (5), 717-23
DOI 10.1177/1741826711398425, PubMed 21450598

Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
BMC Infect Dis, 11, 75
DOI 10.1186/1471-2334-11-75, PubMed 21435254

Byrkjeland R, Nilsson BB, Westheim AS, Arnesen H, Seljeflot I (2011)
Inflammatory markers as related to disease severity in patients with chronic heart failure: limited effects of exercise training
Scand J Clin Lab Invest, 71 (7), 598-605
DOI 10.3109/00365513.2011.598943, PubMed 21831004

Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) (2011)
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Atherosclerosis, 217 (1), 3-46
DOI 10.1016/j.atherosclerosis.2011.06.028, PubMed 21882396

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H et al. (2011)
Dronedarone in high-risk permanent atrial fibrillation
N Engl J Med, 365 (24), 2268-76
DOI 10.1056/NEJMoa1109867, PubMed 22082198

European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees (2011)
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Eur Heart J, 32 (14), 1769-818
DOI 10.1093/eurheartj/ehr158, PubMed 21712404

Finsen AV, Lunde IG, Sjaastad I, Østli EK, Lyngra M, Jarstadmarken HO, Hasic A, Nygård S, Wilcox-Adelman SA, Goetinck PF, Lyberg T, Skrbic B, Florholmen G, Tønnessen T, Louch WE, Djurovic S, Carlson CR, Christensen G (2011)
Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway
PLoS One, 6 (12), e28302
DOI 10.1371/journal.pone.0028302, PubMed 22164265

Ghanavatian S, Stein RA, Atar D, Hole L, Agewall S (2011)
The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction
Clin Lab, 57 (9-10), 771-6
PubMed 22029194

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P et al. (2011)
Apixaban versus warfarin in patients with atrial fibrillation
N Engl J Med, 365 (11), 981-92
DOI 10.1056/NEJMoa1107039, PubMed 21870978

Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K (2011)
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Circulation, 125 (2), 346-53
DOI 10.1161/CIRCULATIONAHA.111.049759, PubMed 22147903

Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Hammer-Hansen S, Køber L, Willenheimer R, Wachtell K (2011)
Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data)
Am J Cardiol, 108 (4), 541-7
DOI 10.1016/j.amjcard.2011.03.084, PubMed 21624542

Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Nienaber CA, Ray S, Egstrup K, Pedersen TR, Køber L, Willenheimer R, Wachtell K (2011)
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Int J Cardiol, 166 (1), 72-6
DOI 10.1016/j.ijcard.2011.09.064, PubMed 21996417

Grimsmo J, Maehlum S, Moelstad P, Arnesen H (2011)
Mortality and cardiovascular morbidity among long-term endurance male cross country skiers followed for 28-30 years
Scand J Med Sci Sports, 21 (6), e351-8
DOI 10.1111/j.1600-0838.2011.01307.x, PubMed 21477204

Grøgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A (2011)
Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris
Scand J Clin Lab Invest, 71 (4), 322-9
DOI 10.3109/00365513.2011.565367, PubMed 21463159

Hallén J, Jensen JK, Buser P, Jaffe AS, Atar D (2011)
Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction
Acute Card Care, 13 (1), 48-51
DOI 10.3109/17482941.2010.538698, PubMed 21244230

Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, ESC Committee for Practice Guidelines (2011)
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
Eur Heart J, 32 (23), 2999-3054
DOI 10.1093/eurheartj/ehr236, PubMed 21873419

Hassellund SS, Flaa A, Sandvik L, Kjeldsen SE, Rostrup M (2011)
Effects of anthocyanins on blood pressure and stress reactivity: a double-blind randomized placebo-controlled crossover study
J Hum Hypertens, 26 (6), 396-404
DOI 10.1038/jhh.2011.41, PubMed 21544087

Hodt A, Hisdal J, Stugaard M, Stranden E, Atar D, Steine K (2011)
Reduced preload elicits increased LV twist in healthy humans: an echocardiographic speckle-tracking study during lower body negative pressure
Clin Physiol Funct Imaging, 31 (5), 382-9
DOI 10.1111/j.1475-097X.2011.01029.x, PubMed 21771258

Holm S, Ueland T, Dahl TB, Michelsen AE, Skjelland M, Russell D, Nymo SH, Krohg-Sørensen K, Clausen OP, Atar D, Januzzi JL, Aukrust P, Jensen JK, Halvorsen B (2011)
Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke
PLoS One, 6 (12), e28785
DOI 10.1371/journal.pone.0028785, PubMed 22174896

Holme I, Pedersen TR, Boman K, Egstrup K, Gerdts E, Kesäniemi YA, Malbecq W, Ray S, Rossebø AB, Wachtell K, Willenheimer R, Gohlke-Bärwolf C (2011)
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis
Heart, 98 (5), 377-83
DOI 10.1136/heartjnl-2011-300475, PubMed 22155702

Hopp E, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ (2011)
Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study
J Cardiovasc Magn Reson, 13, 22
DOI 10.1186/1532-429X-13-22, PubMed 21414223

Hussain RI, Afzal F, Mørk HK, Aronsen JM, Sjaastad I, Osnes JB, Skomedal T, Levy FO, Krobert KA (2011)
Cyclic AMP-dependent inotropic effects are differentially regulated by muscarinic G(i)-dependent constitutive inhibition of adenylyl cyclase in failing rat ventricle
Br J Pharmacol, 162 (4), 908-16
DOI 10.1111/j.1476-5381.2010.01097.x, PubMed 21039419

Jensen JK, Hallén J, Lund T, Madsen LH, Grieg Z, Januzzi JL, Atar D (2011)
Troponin I degradation in serum of patients with acute ischemic stroke
Scand J Clin Lab Invest, 71 (1), 74-80
DOI 10.3109/00365513.2010.542485, PubMed 21214502

Julius S, Palatini P, Kjeldsen SE, Zanchetti A, Weber MA, McInnes GT, Brunner HR, Mancia G, Schork MA, Hua TA, Holzhauer B, Zappe D, Majahalme S, Jamerson K, Koylan N (2011)
Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension
Am J Cardiol, 109 (5), 685-92
DOI 10.1016/j.amjcard.2011.10.025, PubMed 22169130

Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, Erlund I, Serafini M, Bastani N, Remberg SF, Borge GI, Carlsen MH, Bøhn SK, Myhrstad MC, Dragsted LO, Duttaroy AK, Haffner K, Laake P, Drevon CA, Arnesen H, Collins A, Tonstad S, Blomhoff R (2011)
Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers
Br J Nutr, 106 (4), 557-71
DOI 10.1017/S0007114511000353, PubMed 21806852

Kirkhus B, Lamglait A, Eilertsen KE, Falch E, Haider T, Vik H, Hoem N, Hagve TA, Basu S, Olsen E, Seljeflot I, Nyberg L, Elind E, Ulven SM (2011)
Effects of similar intakes of marine n-3 fatty acids from enriched food products and fish oil on cardiovascular risk markers in healthy human subjects
Br J Nutr, 107 (9), 1339-49
DOI 10.1017/S0007114511004508, PubMed 21917191

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GO (2011)
Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
BMC Endocr Disord, 11, 14
DOI 10.1186/1472-6823-11-14, PubMed 21801387

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2011)
Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction
J Thromb Haemost, 9 (8), 1468-74
DOI 10.1111/j.1538-7836.2011.04377.x, PubMed 21624046

Kubon C, Mistry NB, Grundvold I, Halvorsen S, Kjeldsen SE, Westheim AS (2011)
The role of beta-blockers in the treatment of chronic heart failure
Trends Pharmacol Sci, 32 (4), 206-12
DOI 10.1016/j.tips.2011.01.006, PubMed 21376403

Larsen KO, Yndestad A, Sjaastad I, Løberg EM, Goverud IL, Halvorsen B, Jia J, Andreassen AK, Husberg C, Jonasson S, Lipp M, Christensen G, Aukrust P, Skjønsberg OH (2011)
Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation
Am J Physiol Lung Cell Mol Physiol, 301 (1), L50-9
DOI 10.1152/ajplung.00048.2010, PubMed 21498626

Lunde IG, Aronsen JM, Kvaløy H, Qvigstad E, Sjaastad I, Tønnessen T, Christensen G, Grønning-Wang LM, Carlson CR (2011)
Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure
Physiol Genomics, 44 (2), 162-72
DOI 10.1152/physiolgenomics.00016.2011, PubMed 22128088

Melki D, Lind S, Agewall S, Jernberg T (2011)
Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations
Scand Cardiovasc J, 45 (4), 198-204
DOI 10.3109/14017431.2011.565792, PubMed 21428843

Mistry N, Abdelnoor M, Seljeflot I, Hoffmann P, Bøhmer E, Bjørnerheim R, Kjeldsen SE, Halvorsen S (2011)
Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels 3 months after myocardial infarction are more strongly associated with magnetic resonance-determined ejection fraction than NTproBNP levels in the acute phase
J Card Fail, 17 (6), 479-86
DOI 10.1016/j.cardfail.2011.02.006, PubMed 21624736

Mistry N, Beitnes JO, Halvorsen S, Abdelnoor M, Hoffmann P, Kjeldsen SE, Smith G, Aakhus S, Bjørnerheim R (2011)
Assessment of left ventricular function in ST-elevation myocardial infarction by global longitudinal strain: a comparison with ejection fraction, infarct size, and wall motion score index measured by non-invasive imaging modalities
Eur J Echocardiogr, 12 (9), 678-83
DOI 10.1093/ejechocard/jer113, PubMed 21810829

Munkvik M, Lunde PK, Aronsen JM, Birkeland JA, Sjaastad I, Sejersted OM (2011)
Attenuated fatigue in slow twitch skeletal muscle during isotonic exercise in rats with chronic heart failure
PLoS One, 6 (7), e22695
DOI 10.1371/journal.pone.0022695, PubMed 21799933

Nilsson L, Hallén J, Atar D, Jonasson L, Swahn E (2011)
Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction
Heart, 98 (1), 31-6
DOI 10.1136/heartjnl-2011-300079, PubMed 21727201

O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U et al. (2011)
Effect of nesiritide in patients with acute decompensated heart failure
N Engl J Med, 365 (1), 32-43
DOI 10.1056/NEJMoa1100171, PubMed 21732835

Okin PM, Kjeldsen SE, Dahlöf B, Devereux RB (2011)
Racial differences in incident heart failure during antihypertensive therapy
Circ Cardiovasc Qual Outcomes, 4 (2), 157-64
DOI 10.1161/CIRCOUTCOMES.110.960112, PubMed 21304095

Okin PM, Kjeldsen SE, Julius S, Dahlöf B, Devereux RB (2011)
Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study
Heart Rhythm, 9 (4), 531-7
DOI 10.1016/j.hrthm.2011.11.008, PubMed 22079554

Okin PM, Kjeldsen SE, Julius S, Hille DA, Dahlöf B, Devereux RB (2011)
Effect of changing heart rate during treatment of hypertension on incidence of heart failure
Am J Cardiol, 109 (5), 699-704
DOI 10.1016/j.amjcard.2011.10.026, PubMed 22154318

Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators (2011)
Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study
Eur J Heart Fail, 13 (4), 384-91
DOI 10.1093/eurjhf/hfq224, PubMed 21239405

Olsen MH, Wachtell K, Ibsen H, Lindholm L, Kjeldsen SE, Omvik P, Nieminen MS, Dahlöf B, Okin PM, Devereux RB (2011)
Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy
J Hypertens, 29 (5), 997-1004
DOI 10.1097/HJH.0b013e328344daa3, PubMed 21358415

Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2011)
Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study
Cardiovasc Diabetol, 10, 110
DOI 10.1186/1475-2840-10-110, PubMed 22141572

Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I (2011)
Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease
Clin Chim Acta, 413 (1-2), 113-20
DOI 10.1016/j.cca.2011.09.004, PubMed 21963461

Patrono C, Andreotti F, Arnesen H, Badimon L, Baigent C, Collet JP, De Caterina R, Gulba D, Huber K, Husted S, Kristensen SD, Morais J, Neumann FJ, Rasmussen LH, Siegbahn A, Steg PG, Storey RF, Van de Werf F, Verheugt F (2011)
Antiplatelet agents for the treatment and prevention of atherothrombosis
Eur Heart J, 32 (23), 2922-32
DOI 10.1093/eurheartj/ehr373, PubMed 22019823

Pettersen AA, Arnesen H, Opstad TB, Seljeflot I (2011)
The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel
Thromb J, 9, 4
DOI 10.1186/1477-9560-9-4, PubMed 21426546

Provan SA, Angel K, Semb AG, Mowinckel P, Agewall S, Atar D, Kvien TK (2011)
Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year followup study of 108 patients with rheumatoid arthritis
J Rheumatol, 38 (4), 606-12
DOI 10.3899/jrheum.100689, PubMed 21239744

Provan SA, Semb AG, Hisdal J, Stranden E, Agewall S, Dagfinrud H, Angel K, Atar D, Kvien TK (2011)
Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study
Ann Rheum Dis, 70 (5), 812-7
DOI 10.1136/ard.2010.141523, PubMed 21288959

Reiner Ž, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegría E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs RH, Kjekshus JK, Perrone Filardi P, Riccardi G, Storey RF, David W, Clinical Practice Guidelines Committee of the Spanish Society of Cardiology (2011)
[ESC/EAS Guidelines for the management of dyslipidaemias]
Rev Esp Cardiol, 64 (12), 1168.e1-1168.e60
DOI 10.1016/j.recesp.2011.09.014, PubMed 22115524

Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A et al. (2011)
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
Trials, 12, 252
DOI 10.1186/1745-6215-12-252, PubMed 22129158

Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2011)
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
Lancet, 377 (9767), 741-50
DOI 10.1016/S0140-6736(11)60104-9, PubMed 21316752

Schwartz T, Sanner H, Husebye T, Flatø B, Sjaastad I (2011)
Cardiac dysfunction in juvenile dermatomyositis: a case-control study
Ann Rheum Dis, 70 (5), 766-71
DOI 10.1136/ard.2010.137968, PubMed 21216816

Serebruany VL, Miller M, Pokov AN, Lynch D, Jensen JK, Hallén J, Atar D (2011)
Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia
Cardiology, 118 (3), 187-94
DOI 10.1159/000329300, PubMed 21701167

Skretteberg PT, Grundvold I, Kjeldsen SE, Erikssen JE, Sandvik L, Liestøl K, Erikssen G, Pedersen TR, Bodegard J (2011)
HDL-cholesterol and prediction of coronary heart disease: modified by physical fitness? A 28-year follow-up of apparently healthy men
Atherosclerosis, 220 (1), 250-6
DOI 10.1016/j.atherosclerosis.2011.10.009, PubMed 22062589

Smedbakken L, Jensen JK, Hallén J, Atar D, Januzzi JL, Halvorsen B, Aukrust P, Ueland T (2011)
Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke
Stroke, 42 (9), 2453-8
DOI 10.1161/STROKEAHA.110.612440, PubMed 21757661

Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2011)
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction
Thromb Res, 130 (5), 765-8
DOI 10.1016/j.thromres.2011.11.045, PubMed 22192151

Søraas CL, Larstorp AC, Mangschau A, Tønnessen T, Kjeldsen SE, Bjørnerheim R (2011)
Echocardiographic demonstration of improved myocardial function early after coronary artery bypass graft surgery
Interact Cardiovasc Thorac Surg, 12 (6), 946-51
DOI 10.1510/icvts.2010.260414, PubMed 21422155

Steg PG, Huber K, Andreotti F, Arnesen H, Atar D, Badimon L, Bassand JP, De Caterina R, Eikelboom JA, Gulba D, Hamon M, Helft G, Fox KA, Kristensen SD, Rao SV, Verheugt FW, Widimsky P, Zeymer U, Collet JP (2011)
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology
Eur Heart J, 32 (15), 1854-64
DOI 10.1093/eurheartj/ehr204, PubMed 21715717

Stensaeth KH, Hoffmann P, Fossum E, Mangschau A, Sandvik L, Klow NE (2011)
Cardiac magnetic resonance visualizes acute and chronic myocardial injuries in myocarditis
Int J Cardiovasc Imaging, 28 (2), 327-35
DOI 10.1007/s10554-011-9812-7, PubMed 21347598

Svensson-Färbom P, Wahlstrand B, Almgren P, Dahlberg J, Fava C, Kjeldsen S, Hedner T, Melander O (2011)
A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients
J Hypertens, 29 (2), 388-95
DOI 10.1097/HJH.0b013e3283410390, PubMed 21052022

Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Perrone Filardi P, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines 2008-2010 and 2010-2012 Committees (2011)
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Atherosclerosis, 217 Suppl 1, S1-44
DOI 10.1016/j.atherosclerosis.2011.06.012, PubMed 21723445

Tømte O, Andersen GØ, Jacobsen D, Drægni T, Auestad B, Sunde K (2011)
Strong and weak aspects of an established post-resuscitation treatment protocol-A five-year observational study
Resuscitation, 82 (9), 1186-93
DOI 10.1016/j.resuscitation.2011.05.003, PubMed 21636202

Tømte Ø, Drægni T, Mangschau A, Jacobsen D, Auestad B, Sunde K (2011)
A comparison of intravascular and surface cooling techniques in comatose cardiac arrest survivors
Crit Care Med, 39 (3), 443-9
DOI 10.1097/CCM.0b013e318206b80f, PubMed 21169821

Ueland T, Aukrust P, Dahl CP, Husebye T, Solberg OG, Tønnessen T, Aakhus S, Gullestad L (2011)
Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis
J Intern Med, 270 (5), 452-60
DOI 10.1111/j.1365-2796.2011.02393.x, PubMed 21623962

Ueland T, Smedbakken LM, Hallén J, Atar D, Januzzi JL, Halvorsen B, Jensen JK, Aukrust P (2011)
Soluble CXCL16 and long-term outcome in acute ischemic stroke
Atherosclerosis, 220 (1), 244-9
DOI 10.1016/j.atherosclerosis.2011.10.004, PubMed 22055341

Von Lueder TG, Melsom MN, Atar D, Agewall S (2011)
Amyotrophic lateral sclerosis (ALS), a novel rare cause of elevated plasma troponin T levels
Clin Lab, 57 (7-8), 615-8
PubMed 21888026

Waehre A, Halvorsen B, Yndestad A, Husberg C, Sjaastad I, Nygård S, Dahl CP, Ahmed MS, Finsen AV, Reims H, Louch WE, Hilfiker-Kleiner D, Vinge LE, Roald B, Attramadal H, Lipp M, Gullestad L, Aukrust P, Christensen G (2011)
Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload
PLoS One, 6 (4), e18668
DOI 10.1371/journal.pone.0018668, PubMed 21533157

Weir MR, Bakris GL, Weber MA, Dahlof B, Devereux RB, Kjeldsen SE, Pitt B, Wright JT, Kelly RY, Hua TA, Hester RA, Velazquez E, Jamerson KA (2011)
Renal outcomes in hypertensive Black patients at high cardiovascular risk
Kidney Int, 81 (6), 568-76
DOI 10.1038/ki.2011.417, PubMed 22189843

Weiss TW, Arnesen H, Trøseid M, Kaun C, Hjerkinn EM, Huber K, Wojta J, Seljeflot I (2011)
Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose
Wien Klin Wochenschr, 123 (21-22), 650-4
DOI 10.1007/s00508-011-0028-6, PubMed 21842238

Weiss TW, Seljeflot I, Hjerkinn EM, Arnesen H (2011)
Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease
Int J Clin Pract, 65 (9), 939-44
DOI 10.1111/j.1742-1241.2011.02717.x, PubMed 21849008